Unexpected metastatic pheochromocytoma - An unusual presentation

European Journal of Internal Medicine

Volumn 19, Issue 1, 2008, Pages 60-62

  Birrenbach, Tanja ^a   Stanga, Zeno ^a   Cottagnoud, Philippe ^a   Stucki, Armin ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Pneumology   (Switzerland)

Author keywords

Dopamine; Hypertension; Malignancy; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CHROMOGRANIN A; PENTETREOTIDE IN 111; PHENOXYBENZAMINE; SOMATOSTATIN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BIOCHEMISTRY; CANCER DIAGNOSIS; CANCER RISK; CANCER SCINTISCANNING; CANCER SURGERY; CASE REPORT; DISTANT METASTASIS; HUMAN; LABORATORY DIAGNOSIS; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; TUMOR VOLUME; URINALYSIS;

ADRENAL GLAND NEOPLASMS; DOPAMINE; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA;

EID: 38349022221     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.02.029     Document Type: Article

References (6)

1. Shen W.T., Sturgeon C., Clark O.H., Duh Q.-Y., and Kebebew E. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery 136 (2004) 1129-1137
2. John H., Ziegler W.H., Hauri D., and Jaeger P. Pheochromocytomas: can malignant potential be predicted?. Urology 53 (1999) 679-683
3. Lucon A.M., Pereira M.A.A., Mendonca B.B., Halpern A., Wajchenbeg B.L., and Arap S. Pheochromocytoma: study of 50 cases. J Urol 157 (1997) 1208-1212
4. Glodny B., Winde G., Herwig R., et al. Clinical differences between benign and malignant pheochromocytomas. Endocr J 48 (2001) 151-159
5. Van der Harst E., de Herder W., de Krijger R., et al. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol 147 (2002) 85-94
6. Kaltsas G., Korbonits M., Heintz J., et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86 (2001) 895-902